Partner Article
Aesica led consortium wins grant for chemical manufacturing project
Newcastle-based Aesica Pharmaceuticals is at the head of a consortium that has secured a Government grant to pursue new sustainable chemical manufacturing processes.
Aesica leads Charnwood Technical Consulting, CatScI and Biocatalysts, as a consortium that has won Technology Strategy Board funding to focus on establishing an industrial biotechnology aimed at improving sustainability in manufacturing of an active pharmaceutical ingredient.
The overall project is estimated to be worth £200k and Aesica will have responsibility for the delivery of scale-up studies to determine feasibility of the technology on a bigger scale.
Dr Barrie Rhodes, director of Technology Development at Aesica said: “We are delighted that our project successfully secured such Technology Strategy Board funding and are naturally very pleased to be leading a consortium consisting of such highly experienced companies.
“At Aesica, we are committed to innovation and fostering effective partnerships to further good science. Indeed, bringing together such strong technical expertise and know-how to combine high value chemical manufacturing with industrial biotechnology is a prime example of what we are about.”
This was posted in Bdaily's Members' News section by Tom Keighley .
Enjoy the read? Get Bdaily delivered.
Sign up to receive our daily bulletin, sent to your inbox, for free.
Improving safety and standards across construction
From economic engine to community ecosystem
Improving North East transport will improve lives
Unlocking investment potential before year end
Give us certainty to deliver better homes
Hormuz: Safe passage - not insurance - the issue
Don't get caught out by employment law change
When literacy thrives, our businesses thrive too
Building a more diverse construction sector
The value of using data like a Premier League club
Raising the bar to boost North East growth
Navigating the messy middle of business growth